Erratum: Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency (Immunity (2017) 46(1) (148–161) (S1074761316304770) (10.1016/j.immuni.2016.11.005));Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency

Immunity

Volumn 46, Issue 1, 2017, Pages 148-161

  Simoni, Yannick ^a   Fehlings, Michael ^a   Kløverpris, Henrik N ^b,c   McGovern, Naomi ^a   Koo, Si Lin ^d   Loh, Chiew Yee ^a   Lim, Shawn ^a   Kurioka, Ayako ^e   Fergusson, Joannah R ^e   Tang, Choong Leong ^f   Kam, Ming Hian ^f   Dennis, Koh ^f,g   Lim, Tony Kiat Hon ^f   Fui, Alexander Chung Yaw ^f   Hoong, Chan Weng ^f   Chan, Jerry Kok Yen ^h,i   Curotto de Lafaille, Maria ^a,k   Narayanan, Sriram ^a   Baig, Sonia ^j   Shabeer, Muhammad ^j   Toh, Sue Anne Ee Shiow ^i,j,l,m   Tan, Henry Kun Kiaang ^h   Anicete, Rosslyn ^h   Tan, Eng Huat ^d   Takano, Angela ^f   Klenerman, Paul ^e   Leslie, Alasdair ^b   Tan, Daniel S W ^a,d   Tan, Iain Beehuat ^a,d,i   Ginhoux, Florent ^a   Newell, Evan W ^a   more..

^a AGENCY FOR SCIENCE   (Singapore)

^b AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

^g MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^h KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

ⁱ DUKE NUS MEDICAL SCHOOL   (Singapore)

^j Dept Medicine Endocrinol Diabet   (Singapore)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

CyTOF; human; ieILC1; ILC; ILC1; ILC2; ILC3

Indexed keywords

CELL PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; B LYMPHOCYTE; BASOPHIL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HETEROGENEITY; CELL POPULATION; CYTOKINE PRODUCTION; CYTOMETRY; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SPACE; LUNG PARENCHYMA; LYMPHOID CELL; MASS CYTOMETRY; NATURAL KILLER CELL; PATHOLOGY; PHENOTYPE; PHENOTYPIC VARIATION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; FLOW CYTOMETRY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; PROCEDURES;

FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE SUBSETS; LYMPHOCYTES; PHENOTYPE;

EID: 85008239935     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.04.028     Document Type: Erratum

References (34)

1. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
2. Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer, K., Hreggvidsdottir, H.S., Heinsbroek, S.E., Legrand, N., Buskens, C.J., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14 (2013), 221–229.
3. Bernink, J.H., Krabbendam, L., Germar, K., de Jong, E., Gronke, K., Kofoed-Nielsen, M., Munneke, J.M., Hazenberg, M.D., Villaudy, J., Buskens, C.J., et al. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria. Immunity 43 (2015), 146–160.
4. Björklund, A.K., Forkel, M., Picelli, S., Konya, V., Theorell, J., Friberg, D., Sandberg, R., Mjösberg, J., The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat. Immunol. 17 (2016), 451–460.
5. Boyman, O., Sprent, J., The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12 (2012), 180–190.
6. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., Doherty, J.M., Mills, J.C., Colonna, M., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
7. Diefenbach, A., Colonna, M., Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 41 (2014), 354–365.
8. Dinarello, C.A., Novick, D., Kim, S., Kaplanski, G., Interleukin-18 and IL-18 binding protein. Front. Immunol., 4, 2013, 289.
9. Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., Cella, M., Colonna, M., Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity 38 (2013), 769–781.
10. + innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38 (2013), 1223–1235.
11. Gury-BenAri, M., Thaiss, C.A., Serafini, N., Winter, D.R., Giladi, A., Lara-Astiaso, D., Levy, M., Salame, T.M., Weiner, A., David, E., et al. The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome. Cell 166 (2016), 1231–1246.e13.
12. Hazenberg, M.D., Spits, H., Human innate lymphoid cells. Blood 124 (2014), 700–709.
13. Huang, Y., Guo, L., Qiu, J., Chen, X., Hu-Li, J., Siebenlist, U., Williamson, P.R., Urban, J.F. Jr., Paul, W.E., IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat. Immunol. 16 (2015), 161–169.
14. Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Göppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., Diefenbach, A., A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature 494 (2013), 261–265.
15. Kopcow, H.D., Allan, D.S., Chen, X., Rybalov, B., Andzelm, M.M., Ge, B., Strominger, J.L., Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. USA 102 (2005), 15563–15568.
16. Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007), 371–381.
17. Maazi, H., Patel, N., Sankaranarayanan, I., Suzuki, Y., Rigas, D., Soroosh, P., Freeman, G.J., Sharpe, A.H., Akbari, O., ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42 (2015), 538–551.
18. McKenzie, A.N., Spits, H., Eberl, G., Innate lymphoid cells in inflammation and immunity. Immunity 41 (2014), 366–374.
19. Mjösberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet, B., Fokkens, W.J., Cupedo, T., Spits, H., Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12 (2011), 1055–1062.
20. Morandi, B., Costa, R., Falco, M., Parolini, S., De Maria, A., Ratto, G., Mingari, M.C., Melioli, G., Moretta, A., Ferlazzo, G., Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. J. Immunol. 175 (2005), 3690–3697.
21. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., Ohtani, M., Fujii, H., Koyasu, S., Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
22. Newell, E.W., Cheng, Y., Mass cytometry: blessed with the curse of dimensionality. Nat. Immunol. 17 (2016), 890–895.
23. Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11 (2011), 85–97.
24. Pizarro, T.T., Michie, M.H., Bentz, M., Woraratanadharm, J., Smith, M.F. Jr., Foley, E., Moskaluk, C.A., Bickston, S.J., Cominelli, F., IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162 (1999), 6829–6835.
25. Robinette, M.L., Colonna, M., Innate lymphoid cells and the MHC. HLA 87 (2016), 5–11.
26. Robinette, M.L., Fuchs, A., Cortez, V.S., Lee, J.S., Wang, Y., Durum, S.K., Gilfillan, S., Colonna, M., Immunological Genome Consortium Immunological Genome Consortium. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16 (2015), 306–317.
27. Roediger, B., Kyle, R., Yip, K.H., Sumaria, N., Guy, T.V., Kim, B.S., Mitchell, A.J., Tay, S.S., Jain, R., Forbes-Blom, E., et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14 (2013), 564–573.
28. Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008), 958–970.
29. Serafini, N., Klein Wolterink, R.G., Satoh-Takayama, N., Xu, W., Vosshenrich, C.A., Hendriks, R.W., Di Santo, J.P., Gata3 drives development of RORγt+ group 3 innate lymphoid cells. J. Exp. Med. 211 (2014), 199–208.
30. Serafini, N., Vosshenrich, C.A., Di Santo, J.P., Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 15 (2015), 415–428.
31. Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., Mack, M., Cella, M., Colonna, M., Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212 (2015), 1869–1882.
32. Vely, F., Barlogis, V., Vallentin, B., Neven, B., Piperoglou, C., Perchet, T., Petit, M., Yessaad, N., Touzot, F., Bruneau, J., et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17 (2016), 1291–1299.
33. Vonarbourg, C., Diefenbach, A., Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells. Semin. Immunol. 24 (2012), 165–174.
34. Zhong, C., Cui, K., Wilhelm, C., Hu, G., Mao, K., Belkaid, Y., Zhao, K., Zhu, J., Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat. Immunol. 17 (2015), 169–178.